Compass Point analyst Casey Alexander downgrades Argo Gr Intl Hldgs (NYSE:ARGO) from Buy to Neutral and announces $35 price target.
Aspira Women’s Health Provides A Development Update On Its Portfolio Of Noninvasive Tests For Endometriosis
Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometriomaPlatform migration to begin on the Company's EndoMDx™ test for broader
